| Patent Number |
Title Of Patent |
Date Issued |
| 7226614 |
Tablet comprising cetirizine and pseudoephedrine |
June 5, 2007 |
| The present invention concerns a tablet comprising two distinct segments. More particularly, the invention relates to combinations of two pharmaceutical substances and methods of treatment of allergic disorders. |
| 7083807 |
Pharmaceutical compositions for the controlled release of active substances |
August 1, 2006 |
| The invention relates to pharmaceutical compositions which can be administrated orally, allowing the controlled release of at least one active substance comprising a) the said at least one active substance, b) between 5 and 60% by weight, relative to the total weight of the compositi |
| 7014867 |
Tablet comprising cetirizine and pseudoephedrine |
March 21, 2006 |
| The present invention concerns a tablet comprising two distinct segments. More particularly, the invention relates to combinations of two pharmaceutical substances and methods of treatment of allergic disorders. |
| 6818224 |
Use of gellable pharmaceutical compositions in periodontology |
November 16, 2004 |
| A method is described for preparing a fluid pharmaceutical composition which allows the controlled release of at least one active substance. The method involves mixing a therapeutically effective amount of at least one active substance, from 3 to 55% by weight of phospholipid, from 16 to |
| 6699502 |
Pharmaceutical compositions for controlled release of active substances |
March 2, 2004 |
| The present invention is directed a pharmaceutical composition which can be administered orally, allowing for the controlled release of at least one active substance. The composition includes at least one active substance, between 5 and 60% by weight, relative to the total weight of the |
| 6471970 |
Use of pharmaceutical compositions capable of being gelled in periodontology |
October 29, 2002 |
| A method is described for preparing a fluid pharmaceutical composition which allows the controlled release of at least one active substance. The method involves mixing a therapeutically effective amount of at least one active substance, from 3 to 55% by weight of phospholipid, from 16 to |
| 6464987 |
Pharmaceutical compositions capable of being gelled |
October 15, 2002 |
| A fluid pharmaceutical composition is described which allows the controlled release of at least one active substance. The composition comprises a therapeutically effective amount of at least one active substance, from 3 to 55% by weight of phospholipid, from 16 to 72% by weight of ph |
| 6455533 |
Pharmaceutical compositions for oral administration, comprising an active substance and a cyclod |
September 24, 2002 |
| The invention concerns pharmaceutical compositions for oral administration, comprising an active substance belonging to the family of substituted benzhydrylpiperazines and at least a cyclodextrin. |
| 6335331 |
Pseudopolymorphic forms of 2-[2-[4-[Bis (4-fluorophenyl) methyl]-1-piperazinyl]ethoxy]acetic aci |
January 1, 2002 |
| The present invention relates to new pseudopolymorphic forms of 2-[2-[4-[bis (4-fluorophenyl)methyl]-1-piperazinyl]ethoxy]acetic acid dihydrochloride, namely, anhydrous 2-[2-[4-[bis(4-fluorophenyl)methyl]-1-piperazinyl]ethoxy]acetic acid dihydrochloride and 2-[2-[4-[bis(4-fluorop |
| 6262057 |
Pseudopolymorphic forms of 2-[2-[4-[Bis(4-fluorophenyl)methyl]-1-piperazinyl]ethoxy]acetic acid |
July 17, 2001 |
| The present invention relates to new pseudopolymorphic forms of 2-[2-[4-[bis(4-fluorophenyl)methyl]-1-piperazinyl]ethoxy]acetic acid dihydrochloride, namely, anhydrous 2-[2-[4-[bis(4-fluorophenyl)methyl]-1-piperazinyl]ethoxy]acetic acid dihydrochloride and 2-[2-[-bis(4-fluorophen |
